http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010526878-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6845 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 |
| filingDate | 2008-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2010526878-A |
| titleOfInvention | New treatments for chemical substance addiction |
| abstract | The present invention is a method of treating chemical abuse by selectively inhibiting ghrelin activity in humans, wherein a therapeutically effective amount of ghrelin receptor ligand (GHS-RL) is administered to a human in need thereof. A method comprising steps is provided. The ghrelin receptor ligand (GHS-RL) may be selected from the group consisting of a ghrelin receptor antagonist (GHS-RA), a ghrelin receptor inverse agonist (GHS-RIA) and a ghrelin receptor partial agonist (GHS-RPA). it can. More specifically, the present invention is a method of treating an alcohol-related disorder in a human, wherein the human in need thereof is treated with a ghrelin receptor antagonist (GHS-RA), a ghrelin receptor inverse agonist (GHS-RIA). And a therapeutically effective amount of a compound that is a ghrelin receptor ligand (GHS-RL), such as a ghrelin receptor partial agonist (GHS-RPA). |
| priorityDate | 2007-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007020013-A2 |
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467260294 |
Total number of triples: 21.